AF
TARS icon

Allworth Financial’s Tarsus Pharmaceuticals TARS Stock Holding History

Allworth Financial’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.34K Buy
69
+12
+21% +$767 ﹤0.01% 4199
2026
Q1 		$4K Buy
57
+2
+4% +$140 ﹤0.01% 4078
2025
Q4 		$4.5K Buy
55
+22
+67% +$1.64K ﹤0.01% 3777
2025
Q3 		$1.96K Buy
33
+9
+38% +$443 ﹤0.01% 4011
2025
Q2 		$973 Buy
+24
New +$1.08K ﹤0.01% 3965
2024
Q3 		– Sell
-21
Closed -$568 – 3831
2024
Q2 		$568 Hold
21
– – ﹤0.01% 3340
2024
Q1 		$764 Buy
+21
New +$617 ﹤0.01% 3160
2022
Q4 		– Sell
-12
Closed – – 3188
2022
Q3 		$0 Buy
+12
New +$191 ﹤0.01% 3094

Other funds holding TARS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Allworth Financial's TARS Position: Q2 2026 in Review

Allworth Financial increased its Tarsus Pharmaceuticals (TARS) stake by 21% in Q2 2026, buying an estimated $767 and bringing the position to 69 shares worth $4.34K. The position accounts for ﹤0.01% of the portfolio, ranked #4199.

Allworth Financial first reported a position in TARS in Q3 2022 and has held it in 8 quarters since. The position peaked at $4.5K in Q4 2025. 257 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

  • Allworth Financial held 69 shares of Tarsus Pharmaceuticals worth $4.34K as of Q2 2026.
  • Allworth Financial bought 12 Tarsus Pharmaceuticals shares in Q2 2026, an estimated $767.
  • Tarsus Pharmaceuticals made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #4199 holding.
  • Allworth Financial first reported a position in Tarsus Pharmaceuticals in Q3 2022 and has held it in 8 quarters since.
  • Allworth Financial's Tarsus Pharmaceuticals position peaked at $4.5K in Q4 2025.
  • 257 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.